Checkmate Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Checkmate Pharmaceuticals Stock Forecast and Price Target
Checkmate Pharmaceuticals has an average price target of $126.60 recently offered by notable experts for 2024, which would represent a potential upside of approximately 14.57% from the last closing price in November, 2023 if reached. This potential increase is based on a high estimate of $141.79 and a low estimate of $112.67.
14.57% Upside
Checkmate Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
Checkmate Pharmaceuticals's Price has increased by 100.00% In the last two years, going from $0.00 to $0.00. In the next year, analysts expect Fair Value to reach $118.76 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
.jpg)
Checkmate Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last year, Checkmate Pharmaceuticals's EBIT has grown by 66.59%, rising from $-36.90M to $-61.47M. 0 analysts predict Checkmate Pharmaceuticals's EBIT will decrease by 39.97% in the next year, reaching $-36.90M. By 2030, professionals predict that Checkmate Pharmaceuticals's EBIT will decrease by 17.85%, to $-50.50M.
Checkmate Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
Checkmate Pharmaceuticals's EPS has increased by 100.00% In the last two years, going from $-3.64 to $0.00. In the next year, analysts expect EPS to reach $0.00 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)